Table 1.
Characteristic | Kaposi sarcoma | ||
---|---|---|---|
Total (%) | Negative (%) | Positive (%) | |
Age (years) | |||
0–18 | 189(17.2) | 188(17.9) | 1(2) |
19–34 | 481(43.7) | 463(44.1) | 18(35.3) |
35+ | 430(39.1) | 398(37.9) | 32(62.7) |
Gender | |||
Male | 429(39) | 398(37.9) | 31(60.8) |
Female | 671(61) | 651(62.1) | 20(39.2) |
Marital status | |||
Married | 546(49.6) | 512(48.8) | 34(66.7) |
Divorced(widowed | 212(19.3) | 206(19.6) | 6(11.8) |
Single | 342(31.1) | 331(31.6) | 11(21.6) |
Residence | |||
Urban | 482(43.8) | 464(44.2) | 18(35.3) |
Rural | 618(56.2) | 585(55.8) | 33(64.7) |
Occupation | |||
Student | 275(25) | 270(25.7) | 5(9.8) |
Employee | 150(13.6) | 139(13.3) | 11(21.6) |
Business | 282(25.6) | 272(25.9) | 10(19.6) |
Peasant | 393(35.7) | 368(35.1) | 25(49) |
Education level | |||
No formal education | 95(8.6) | 87(8.3) | 8(15.7) |
Primary | 677(61.5) | 650(62) | 27(52.9) |
Secondary | 241(21.9) | 233(22.2) | 8(15.7) |
College | 87(7.9) | 79(7.5) | 8(15.7) |
Smoking | |||
Smoker | 241(21.9) | 216(20.6) | 25(49) |
Non smoker | 859(78.1) | 833(79.4) | 26(51) |
Visit to traditional healers | |||
No | 913(83) | 885(84.4) | 28(54.9) |
Yes | 187(17) | 164(15.6) | 23(45.1) |
ART use | |||
ART user | 807(73.4) | 767(73.1) | 40(78.4) |
Non ART user | 293(26.6) | 282(26.9) | 11(21.6) |
CD4 count | |||
0–200 | 405(36.8) | 364(34.7) | 41(80.4) |
201–600 | 531(48.3) | 522(49.8) | 9(17.6) |
601+ | 164(14.9) | 163(15.5) | 1(2) |
History of STIs | |||
Have STI | 208(18.9) | 192(18.3) | 16(31.4) |
No STI | 892(81.1) | 857(81.7) | 35(68.6) |
The table summarizes the socio-demographic and prevalence characteristics of the 1100 patients included in this study. The general characteristics of the study population are summarized. Furthermore, we observed more KS positivity in older patients above 35 years. More male patients were also KS positive compared to female HIV positive patients. Other patients’ characteristics which were more common on KS patients were smoking, attending traditional healers and low CD4+ counts